Influence of Hemodialysis Treatment on Biochemical Markers of Bone Disease
BANTAO Journal · 2017
DOI: 10.1515/bj-2017-0004 ↗Kurz gefasst
Fachartikel in der Zeitschrift BANTAO Journal, 2017. Verfasst von Aida Coric und 7 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Introduction
Bone disease is a chronic complication of chronic kidney disease and major clinical problem in hemodialysis (HD) patients. The aim of our study was to assess the influence of treatment longevity on biochemical parameters of mineral and bone metabolism in HD patients, and to identify the most important parameters.
Methods
The research was observational and retrospective, involved 70 patients, mean age 58.69±12.54, divided into groups in respect to the duration of dialysis treatment (Group I-5 years, Group II-5-10 years and Group III-over 10 years).
Results
Serum phosphorus was increased, but the values tend to increase along with dialysis duration - (Group I: 1.93±0.45; Group II: 1.97±0.50; Group III: 2.01±0.37; p>0,05). Calcium values were also not significantly increased based on the duration of treatment [Group I: 2.3 (2.2-2.41); Group II: 2.46 (2.15-2.6), Group III: 2.35 (2.10-2.52)]. Dialysis and PTH correlated positively in the first group of patients (Rho=0.470, p=0.013). The values of calcium and alkaline phosphatase correlated positively in all patients (Rho=0.351, p=0.003). PTH was significantly higher in the second and third compared to the first group (p=0.009 and p=0.038, respectively), and there was no significant difference between the second and the third group. Interestingly, parathyroidectomized patients had higher PTH values compared to those without parathyroidectomy (557 vs. 359 pg/ml).
Conclusion
The most reliable marker for clinical monitoring of bone disease in dialysis patients is PTH. The values of calcium and phosphorus are highly variable and not reliable parameters for bone disease follow-up.
Zitieren
APA
Coric, A., Resic, H., Spasovski, G., Lepara, O., Ajanovic, S., Klapuh, N., Prohic, N., & Beciragic, A. (2017). Influence of Hemodialysis Treatment on Biochemical Markers of Bone Disease. BANTAO Journal. https://doi.org/10.1515/bj-2017-0004
Vancouver
Coric A, Resic H, Spasovski G, Lepara O, Ajanovic S, Klapuh N, et al. Influence of Hemodialysis Treatment on Biochemical Markers of Bone Disease. BANTAO Journal. 2017. doi:10.1515/bj-2017-0004
BibTeX
@article{Coric2017,
author = {Coric, Aida and Resic, Halima and Spasovski, Goce and Lepara, Orhan and Ajanovic, Selma and Klapuh, Nermina and Prohic, Nejra and Beciragic, Amela},
title = {Influence of Hemodialysis Treatment on Biochemical Markers of Bone Disease},
journal = {BANTAO Journal},
year = {2017},
doi = {10.1515/bj-2017-0004}
}
EUVIMED